Cortical Contributions to FFR: Post-Op Outcomes
Launched by UNIVERSITY OF PITTSBURGH · Jan 27, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The purpose of this study is to better understand the cortical contribution of the human temporal lobe to the generation and modulation of frequency-following responses (FFR).
The specific aims of this study is as follows:
1. To build a novel computational model of cortical feedforward mechanisms involved in FFRs.
2. To test model predictions of cortical removal in human participants who have undergone surgical resection of Heschl's gyrus lesions.
The hypothesis to be tested for the previously listed purposes and aims are as follows:
1. When cortical areas involved in generating and mod...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals 13-25 years old
- • Undergoing medically necessary surgical resection of Heschl's gyrus lesion
- • Monolingual English speakers
- • Receptive and expressive language within normal limits
- • Normal or corrected-to-normal visual acuity
- • Normal hearing acuity in each ear (as determined during an audiometric assessment)
- • Nonverbal IQ within normal limits
- • No history of autism spectrum disorder or attention-deficit hyperactivity disorder
- Exclusion Criteria:
- • Significant medical or neuropsychological impairment that would result in the patient being unable to participate in study activities
- • History of autism or ADHD
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Taylor Abel, MD
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials